News

Inari Medical Achieves Record Q3 Revenues, Eyes Future Growth

Inari Medical Achieves Record Q3 Revenues, Eyes Future Growth

Inari Medical Reports Record Revenue in Q3

Inari Medical Inc. (NARI) has showcased impressive financial results for its third quarter, generating record revenues of $153.4 million. This marks a 21% increase compared to the same period last year, demonstrating the company's robust growth in the medical device sector, particularly in thrombectomy procedures. The management has adjusted its full-year revenue forecast upwards, now predicting total revenues between $601.5 million and $604.5 million.

Despite facing a GAAP operating loss this quarter, Inari Medical is optimistic about its prospects for achieving operating profitability in the first half of 2025. Growth has been driven by significant international sales, notably in Europe and Latin America, aided by the acquisition of necessary regulatory approvals in key markets such as Brazil, China, and Japan.

Highlights from Financial Performance

This quarter marked a successful period for Inari Medical with the following key financial takeaways:

  • The company reported a substantial year-over-year revenue increase of 21% for Q3 2024.
  • International revenue surged by 76.4%, particularly strong in Europe and Latin America.
  • The company has raised its 2024 revenue outlook significantly.
  • Inari reported a GAAP operating loss of $13.6 million and a net loss of $18.4 million this quarter.
  • Future growth is anticipated due to the upcoming data from the PEERLESS trial and the successful launch of new products.

Strategic Company Outlook

Inari Medical is pursuing sustained operating profitability, with ambitious plans for its Emerging Therapies segment, expecting it to contribute significantly to total revenue moving forward. The management is focused on long-term growth and is committed to improving profitability metrics while adhering to consistent historical guidance practices.

Financial Challenges

Although the financial outlook is positive, there are challenges that the company faces:

  • The reported GAAP operating loss of $13.6 million indicates that the company is still navigating a complex financial landscape.
  • Operating expenses have increased, emphasizing the need for careful financial management.

Positive Outlook

On the brighter side, international sales have rebounded significantly, and the company remains confident about the continued adoption of its innovative devices such as LimFlow and Artix. Stable prices in the U.S. VTE market, along with a transition to a new pricing program, are expected to provide additional financial momentum.

Challenges and Misses

Despite the positive revenue, Inari Medical reported a loss per share of $0.31 this quarter, which highlights the contrast between revenue growth and profitability. The net loss widened in comparison to Q3 2023, emphasizing the need to focus on efficiency and cost controls.

Q&A Highlights During Earnings Call

During a recent earnings call, executives discussed the efficacy of the FlowTriever system compared to traditional catheter-directed therapies and highlighted a positive sequential improvement in operating performance. They expressed optimism about future trials, particularly PEERLESS, and the potential market expansion into countries like China and Japan.

Overall, Inari Medical's performance in the third quarter of 2024 illustrates a company poised for growth, strategically enhancing its international presence while working towards sustainable profitability. As they continue to navigate challenges, the company's proactive approach to product development and market expansion positions them well for the future.

Frequently Asked Questions

What were Inari Medical's revenues for Q3 2024?

Inari Medical reported record revenues of $153.4 million for the third quarter of 2024, which is a 21% increase from the previous year.

Which markets saw the most growth for Inari Medical?

The company experienced significant growth in international markets, particularly in Europe and Latin America, where revenues surged by 76.4%.

What is Inari Medical's outlook for profitability?

The company aims to achieve sustained operating profitability in the first half of 2025, guided by a strong performance in its Emerging Therapies segment.

What challenges did Inari Medical face in Q3 2024?

Inari Medical reported a GAAP operating loss of $13.6 million, with increased operating expenses impacting their financial outcomes.

What role will the PEERLESS trial play for Inari Medical?

The PEERLESS trial data is expected to significantly influence future growth and the adoption of Inari's products in the competitive thrombectomy market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Westlake Chemical Partners Schedules Q4 and Year-End Call

Updated Category News Views 158

Westlake Chemical Partners to Announce Earnings Soon Westlake Chemical Partners (NYSE: WLKP), based in Houston, is preparing to release its earnings report for the fourth quarter and full year 2024. This significant announcement is eagerly anticipated by investors and industry analysts alike. The earnings report is scheduled to be released prior to the market opening on a...

Continue Reading
Wabtec's Bold Move: Acquiring Evident's Tech Division

Updated Category News Views 144

Wabtec's Strategic Acquisition of Evident's Inspection Technologies Wabtec Corp, a leader in heavy industrial parts manufacturing, has made headlines with its recent decision to acquire the inspection technologies division of Evident for an impressive $1.78 billion. This acquisition reflects Wabtec's strategy to enhance its portfolio and strengthen its position within the...

Continue Reading
Insight into WisdomTree's Latest Fund Valuations

Updated Category News Views 184

Understanding Net Asset Values in ETFs Investors often seek knowledge about the net asset values (NAVs) of Exchange Traded Funds (ETFs), which play a critical role in determining how funds are valued and traded in the market. For instance, WisdomTree Issuer plc regularly offers updates concerning its funds, revealing the intricate details behind price fluctuations and...

Continue Reading
Investigation Announced Into Electronic Systems Technology, Inc.

Updated Category News Views 239

Investigation of Electronic Systems Technology, Inc. In a noteworthy development, the M&A Class Action Firm has announced an investigation into Electronic Systems Technology, Inc. (OTCMKTS: ELST). This firm, recognized as a top competitor in the 2024 ISS Securities Class Action Services Report, is dedicated to protecting shareholder interests. The firm, led by renowned...

Continue Reading
Fusion CBD Products Partners with Major League Baseball Teams

Updated Category News Views 291

Fusion CBD Products and Major League Baseball: A Growing Partnership Team sponsorship opportunities expand as the league embraces CBD's advantages. As the Major League Baseball (MLB) season unfolds, many players are facing injuries from early training sessions and games. Notable players like Heliot Ramos of the San Francisco Giants and Erik Miller have recently dealt with...

Continue Reading